Edwards Lifesciences press release ( EW ): Q4 Non-GAAP EPS of $0.58 misses by $0.04 . Revenue of $1.57B (+13.8% Y/Y) beats by $30M . Cash and cash equivalents were approximately $3.0 billion as of Dec. 31, 2025. Total debt was approximately $600 million. Outlook Edwards has increased confidence in meeting its 2026 sales growth rate guidance of 8 to 10% and EPS guidance of $2.90 to $3.05. For the f...
Edwards Lifesciences press release ( EW ): Q4 Non-GAAP EPS of $0.58 misses by $0.04 . Revenue of $1.57B (+13.8% Y/Y) beats by $30M . Cash and cash equivalents were approximately $3.0 billion as of Dec. 31, 2025. Total debt was approximately $600 million. Outlook Edwards has increased confidence in meeting its 2026 sales growth rate guidance of 8 to 10% and EPS guidance of $2.90 to $3.05. For the first quarter of 2026, the company projects total sales to be between $1.55 and $1.63 billion and adjusted EPS of $0.70 to $0.76. More on Edwards Lifesciences Edwards Lifesciences Corporation (EW) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price Edwards Lifesciences Corporation (EW) Analyst/Investor Day Transcript Edwards Lifesciences Q4 2025 Earnings Preview Edwards drops JenaValve bid as court sides with FTC to block the deal
Teradata press release ( TDC ): Q4 Non-GAAP EPS of $0.74 beats by $0.18 . Revenue of $421M (+2.9% Y/Y) beats by $21.25M . Fourth quarter Total ARR of $1.522 billion, an increase of 3% as reported and 1% in constant currency from the prior year period Fourth quarter Recurring Revenue of $367 million, up 5% as reported and 3% in constant currency Public cloud ARR increased to $701 million from $609 ...
Teradata press release ( TDC ): Q4 Non-GAAP EPS of $0.74 beats by $0.18 . Revenue of $421M (+2.9% Y/Y) beats by $21.25M . Fourth quarter Total ARR of $1.522 billion, an increase of 3% as reported and 1% in constant currency from the prior year period Fourth quarter Recurring Revenue of $367 million, up 5% as reported and 3% in constant currency Public cloud ARR increased to $701 million from $609 million, an increase of 15% as reported and 13% in constant currency For the full-year of 2026: Total ARR growth of 2% to 4% year-over-year, Recurring revenue in the range of flat to 2% year-over-year, Total revenue range in the range of -2% to flat year-over-year, GAAP diluted EPS is expected to be in the range of $1.26 to $1.36 Non-GAAP diluted EPS is expected to be in the range of $2.55 to $2.65 per share vs $2.55 consensus Cash flow from operations of $330 million to $350 million Free cash flow of $310 million to $330 million For the first quarter of 2026: Recurring revenue in the range of 6% to 8% year-over-year, Total revenue in the range of 1% to 3% year-over-year, GAAP diluted EPS is expected to be in the range of $0.36 to $0.40 per share Non-GAAP diluted EPS is expected to be in the range of $0.75 to $0.79 per share vs $0.68 consensus Shares +16% . More on Teradata Teradata Corporation (TDC) Presents at Barclays 23rd Annual Global Technology Conference Transcript Teradata Corporation (TDC) Presents at UBS Global Technology and AI Conference 2025 Transcript Has A Teradata Turnaround Finally Started Teradata Q4 2025 Earnings Preview Descartes gets an upgrade, while Snowflake, DoubleVerify and GitLab cut at Barclays
Gary Evans, Chairman and CEO of United States Antimony, and Paul Andre Huet, Chairman & CEO of America's Gold & Silver Corporation, join Bloomberg Businessweek to discuss the companies’ plans to work jointly on a state-of-the-art Hydromet processing facility to produce high-grade critical minerals at an increased rate. As well as how US startups and venture investors are eager to reap the benefits...
Gary Evans, Chairman and CEO of United States Antimony, and Paul Andre Huet, Chairman & CEO of America's Gold & Silver Corporation, join Bloomberg Businessweek to discuss the companies’ plans to work jointly on a state-of-the-art Hydromet processing facility to produce high-grade critical minerals at an increased rate. As well as how US startups and venture investors are eager to reap the benefits of the Trump administration’s planned $12 billion initiative to stockpile critical minerals, which provides another national security-driven lifeline to green tech. (Source: Bloomberg)
Assurant press release ( AIZ ): Q4 Non-GAAP EPS of $5.61 beats by $0.11 . Revenue of $3.35B (+8.1% Y/Y) beats by $70M . More on Assurant Assurant: Letting The Cat Out Of The Bag Assurant Q4 2025 Earnings Preview Top 10 large-cap stocks with highest dividend safety grade Seeking Alpha’s Quant Rating on Assurant Historical earnings data for Assurant
Assurant press release ( AIZ ): Q4 Non-GAAP EPS of $5.61 beats by $0.11 . Revenue of $3.35B (+8.1% Y/Y) beats by $70M . More on Assurant Assurant: Letting The Cat Out Of The Bag Assurant Q4 2025 Earnings Preview Top 10 large-cap stocks with highest dividend safety grade Seeking Alpha’s Quant Rating on Assurant Historical earnings data for Assurant
NETSTREIT press release ( NTST ): Q4 FFO of $0.31 in-line. Completed Record Gross Investment Activity of $245.4 Million at 7.5% Blended Cash Yield for Fourth Quarter – – Reaffirms 2026 AFFO Per Share Guidance of $1.35 to $1.39 – – Increases Quarterly Dividend by 2.3% to $0.22 Per Share – – $46.4 Million of Forward Equity Sales through the ATM in January 2026 – – Achieved Investment Grade Rating of...
NETSTREIT press release ( NTST ): Q4 FFO of $0.31 in-line. Completed Record Gross Investment Activity of $245.4 Million at 7.5% Blended Cash Yield for Fourth Quarter – – Reaffirms 2026 AFFO Per Share Guidance of $1.35 to $1.39 – – Increases Quarterly Dividend by 2.3% to $0.22 Per Share – – $46.4 Million of Forward Equity Sales through the ATM in January 2026 – – Achieved Investment Grade Rating of BBB- from Fitch Ratings in December 2025 – 2026 GUIDANCE The Company is reaffirming its full year 2026 AFFO per share guidance in the range of $1.35 to $1.39. The Company continues to expect 2026 net investment activity to range between $350.0 million to $450.0 million and cash G&A to range between $16.0 million to $17.0 million (exclusive of transaction costs and severance payments). In addition, the Company's AFFO per share guidance range includes $0.015 to $0.03 per share of estimated dilution due to the impact of the Company's outstanding forward equity calculated in accordance with the treasury stock method. FY FFO consensus is $1.32 FY Revenue consensus is $224.12M More on NETSTREIT Netstreit: A Texas-Based Retail REIT That Could Keep The Bulls Charging Netstreit: Reliable Yield And Solid Expansion, Yet Shares Appear Fully Priced Top performing retail REITs year to date for 2025 NETSTREIT gets BBB- issuer default rating from Fitch Seeking Alpha’s Quant Rating on NETSTREIT
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE: ARI) today reported results for the quarter and year ended December 31, 2025. Net income available to common stockholders per diluted share of common stock was $0.18 and $0.81 for the quarter and year ended December 31, 2025, respectively. Distributable Earnings (a non-GAAP finan...
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE: ARI) today reported results for the quarter and year ended December 31, 2025. Net income available to common stockholders per diluted share of common stock was $0.18 and $0.81 for the quarter and year ended December 31, 2025, respectively. Distributable Earnings (a non-GAAP financial measure defined below), and Distributable Earnings prior to realized loss on investments and realized gain on litigation settlement per diluted share of common stock were $0.26 and $0.26 for the quarter ended December 31, 2025, respectively and $0.98 and $1.05 for the year ended December 31, 2025, respectively. ARI issued a detailed presentation of the Company’s quarter and year ended December 31, 2025 results, which can be viewed at www.apollocref.com. Conference Call and Webcast The Company will hold a conference call to review fourth quarter and full year 2025 results on February 11, 2026 at 10am ET. To register for the call, please use the following link: https://register-conf.media-server.com/register/BI38479ef1e3ec49b4b441a21cb7cb9b63 After you register, you will receive a dial-in number and unique pin. The Company will also post a link in the Stockholders’ section on ARI’s website for a live webcast. For those unable to listen to the live call or webcast, there will be a webcast replay link posted in the Stockholders’ section on ARI’s website approximately two hours after the call. Distributable Earnings “Distributable Earnings,” a non-GAAP financial measure, is defined as net income available to common stockholders, computed in accordance with GAAP, adjusted for (i) equity-based compensation expense (a portion of which may become cash-based upon final vesting and settlement of awards should the holder elect net share settlement to satisfy income tax withholding), (ii) any unrealized gains or losses or other non-cash items (including depreciation and amortizatio...
You definitely don't want to pass up this opportunity. Overestimating how well your investments will perform can put your retirement savings in big trouble. If you expect a 20% average annual return over the course of your career and you only get a 10% average annual return, you'll wind up with a lot less money than you thought, even though you still made a strong profit. That's why it's generally...
You definitely don't want to pass up this opportunity. Overestimating how well your investments will perform can put your retirement savings in big trouble. If you expect a 20% average annual return over the course of your career and you only get a 10% average annual return, you'll wind up with a lot less money than you thought, even though you still made a strong profit. That's why it's generally best to plan for a lower rate of return on your savings -- with one exception. For many 401(k) owners, there is one way to get a 100% return on their investment year after year. Don't leave your 401(k) match on the table When your employer matches 100% of your 401(k) contributions, up to a certain percentage of your income, you instantly double your money. As long as you don't quit before you're fully vested in the plan, you can be assured of at least a 100% return on your 401(k) contributions. But that's just the start. Your contributions and your employer's match will remain invested for years or even decades. This means you could wind up with a much larger return on that money by retirement. Of course, not everyone with a 401(k) receives a match, and not everyone eligible for a match can claim the full amount. But it's worth getting what you can each year if you qualify for a match. Even a partial match could be worth thousands of dollars today and possibly tens of thousands of dollars by retirement.
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Palantir Technologies (NasdaqGS:PLTR) announced a partnership with Cognizant to accelerate AI driven modernization in healthcare and enterprise operations. The collaboration focuses on deploying Palantir Foundry and its Artificial Intelligence Platform (AIP) across regulated and compl...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Palantir Technologies (NasdaqGS:PLTR) announced a partnership with Cognizant to accelerate AI driven modernization in healthcare and enterprise operations. The collaboration focuses on deploying Palantir Foundry and its Artificial Intelligence Platform (AIP) across regulated and complex environments. The agreement aims to create repeatable models for enterprise grade AI solutions across Cognizant's client base. For Palantir, known for its data platforms in government and defense, this deal broadens its reach in commercial healthcare and enterprise AI. Cognizant brings a large services footprint and existing client relationships, while Palantir contributes Foundry and AIP as core building blocks for data and AI projects. If you are tracking NasdaqGS:PLTR, this partnership highlights how the company is positioning its tools as standard infrastructure for complex, regulated industries. The rollout and scale of real world deployments with Cognizant clients may influence how investors view Palantir's role in broader enterprise AI adoption. Stay updated on the most important news stories for Palantir Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Palantir Technologies. NasdaqGS:PLTR Earnings & Revenue Growth as at Feb 2026 How Palantir Technologies stacks up against its biggest competitors The Cognizant partnership plugs Palantir’s Foundry and Artificial Intelligence Platform directly into large, regulated workflows such as healthcare claims and business process as a service operations, which are areas where data complexity and compliance barriers have traditionally slowed AI projects. For you as an investor, this points to Palantir trying to move from project-by-project wins to more standardized, repeatable AI solutions across a broad enterprise client base that could sit alongsi...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Palantir Technologies (NasdaqGS:PLTR) announced a partnership with Cognizant to accelerate AI driven modernization in healthcare and enterprise operations. The collaboration focuses on deploying Palantir Foundry and its Artificial Intelligence Platform (AIP) across regulated and compl...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Palantir Technologies (NasdaqGS:PLTR) announced a partnership with Cognizant to accelerate AI driven modernization in healthcare and enterprise operations. The collaboration focuses on deploying Palantir Foundry and its Artificial Intelligence Platform (AIP) across regulated and complex environments. The agreement aims to create repeatable models for enterprise grade AI solutions across Cognizant's client base. For Palantir, known for its data platforms in government and defense, this deal broadens its reach in commercial healthcare and enterprise AI. Cognizant brings a large services footprint and existing client relationships, while Palantir contributes Foundry and AIP as core building blocks for data and AI projects. If you are tracking NasdaqGS:PLTR, this partnership highlights how the company is positioning its tools as standard infrastructure for complex, regulated industries. The rollout and scale of real world deployments with Cognizant clients may influence how investors view Palantir's role in broader enterprise AI adoption. Stay updated on the most important news stories for Palantir Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Palantir Technologies. NasdaqGS:PLTR Earnings & Revenue Growth as at Feb 2026 How Palantir Technologies stacks up against its biggest competitors The Cognizant partnership plugs Palantir’s Foundry and Artificial Intelligence Platform directly into large, regulated workflows such as healthcare claims and business process as a service operations, which are areas where data complexity and compliance barriers have traditionally slowed AI projects. For you as an investor, this points to Palantir trying to move from project-by-project wins to more standardized, repeatable AI solutions across a broad enterprise client base that could sit alongsi...
Zillow Group Inc. forecast first-quarter profit that falls short of analyst estimates as the home-search site balances legal costs from ongoing litigation and expenses from the company’s partnership with Redfin. The Seattle-based company said Tuesday it sees adjusted earnings before interest, taxes, depreciation and amortization range with a midpoint of $167.5 million for the three months ending M...
Zillow Group Inc. forecast first-quarter profit that falls short of analyst estimates as the home-search site balances legal costs from ongoing litigation and expenses from the company’s partnership with Redfin. The Seattle-based company said Tuesday it sees adjusted earnings before interest, taxes, depreciation and amortization range with a midpoint of $167.5 million for the three months ending March 31, missing Wall Street’s estimates of $182.7 million. The shares fell as much as 8.6% in postmarket trading. The stock had fallen 20% this year through Tuesday’s close. While the US housing market might find some relief in 2026 after mortgage rates fell to their lowest level since 2022, homebuilders are still not confident about the market’s rebound. Fewer home sales and new home builds as well as high prices spell future challenges for Zillow, which makes more money the more activity there is in the housing market. The company is facing other headwinds too, including multiple lawsuits that question Zillow’s market dominance and Google’s decision to test a new real estate advertising format that could rival Zillow’s services. Chief Executive Officer Jeremy Wacksman said the way to think about the current state of the US housing market is in terms of marginal improvements, such as pricing balancing out and slightly lower mortgage rates. “The slope is in the right direction,” he said in an interview. “The challenge is we still have a long way to go. So we’re planning for a little bit of improvement.” Compass Inc. lost a bid last week to temporarily block Zillow’s ban on listings that have been advertised elsewhere first. The Federal Trade Commission also sued Zillow in September to block a $100 million deal that made the company the exclusive provider of information on apartment rentals offered by Rocket Cos. ’ Redfin. The company reported fourth-quarter adjusted Ebitda of $149 million, which fell short of analyst estimates.
Seeking Alpha More on Gilead Sciences Gilead Sciences: Buy This Stock For Both Dividend And Growth Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade) Gilead Sciences Non-GAAP EPS of $1.86 beats by $0.03, revenue of $7.93B beats by $250M Gilead Q4 preview: Core portfolio, Yeztugo launch keep analysts optimistic ahea...
Seeking Alpha More on Gilead Sciences Gilead Sciences: Buy This Stock For Both Dividend And Growth Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade) Gilead Sciences Non-GAAP EPS of $1.86 beats by $0.03, revenue of $7.93B beats by $250M Gilead Q4 preview: Core portfolio, Yeztugo launch keep analysts optimistic ahead of earnings
Klaviyo press release ( KVYO ): Q4 Non-GAAP EPS of $0.19 beats by $0.02 . Revenue of $350.2M (+29.6% Y/Y) beats by $16.22M . Financial Outlook $ in millions FY26-Q1 Guidance FY26 Guidance Low High Low High Revenue $346 $350 $1,501 $1,509 Year-over-year Growth Rate 23.5% 25.0% 21.5% 22.5% Non-GAAP Operating Income $50 $53 $218 $224 Non-GAAP Operating Margin 14.5% 15.0% 14.5% 15.0% Fully Diluted Sha...
Klaviyo press release ( KVYO ): Q4 Non-GAAP EPS of $0.19 beats by $0.02 . Revenue of $350.2M (+29.6% Y/Y) beats by $16.22M . Financial Outlook $ in millions FY26-Q1 Guidance FY26 Guidance Low High Low High Revenue $346 $350 $1,501 $1,509 Year-over-year Growth Rate 23.5% 25.0% 21.5% 22.5% Non-GAAP Operating Income $50 $53 $218 $224 Non-GAAP Operating Margin 14.5% 15.0% 14.5% 15.0% Fully Diluted Shares Outstanding (Millions) 307 312 Click to enlarge Shares +9.42% AH. More on Klaviyo Klaviyo: Under The Radar, With Strong Growth And Improving Profitability Klaviyo: This Rebound Is Just Getting Started Klaviyo, Inc. (KVYO) Presents at Barclays 23rd Annual Global Technology Conference Transcript Klaviyo Q4 2025 Earnings Preview Klaviyo unveils new ChatGPT app
Pegasystems press release ( PEGA ): Q4 Non-GAAP EPS of $0.76 beats by $0.03 . Revenue of $504.32M (+2.7% Y/Y) beats by $10.69M . Annual Contract Value ( ACV ) grows 17% year over year (14% in constant currency) Pega Cloud ACV increases 33% year over year (28% in constant currency) 2026 guidance of 15% ACV growth, $595M in cash flow from operations, and $575M in free cash flow Increases share repur...
Pegasystems press release ( PEGA ): Q4 Non-GAAP EPS of $0.76 beats by $0.03 . Revenue of $504.32M (+2.7% Y/Y) beats by $10.69M . Annual Contract Value ( ACV ) grows 17% year over year (14% in constant currency) Pega Cloud ACV increases 33% year over year (28% in constant currency) 2026 guidance of 15% ACV growth, $595M in cash flow from operations, and $575M in free cash flow Increases share repurchase authorization by $1B 2026 GAAP Non-GAAP (1) Revenue $2.0 Billion $2.0 Billion Diluted earnings per share $1.87 $2.75 Click to enlarge 2026 Cash provided by operating activities $595 million Free cash flow $575 million Click to enlarge Shares +2.3% . More on Pegasystems Pegasystems: 34% Drop Provides Buying Opportunity Ahead Of Q4 Earnings Pegasystems Inc. (PEGA) Presents at Barclays 23rd Annual Global Technology Conference Transcript Pegasystems Inc. (PEGA) Presents at UBS Global Technology and AI Conference 2025 Transcript Pegasystems Q4 2025 Earnings Preview Enterprise software stocks tumble as analysts mull growth acceleration amid AI impact
Welltower press release ( WELL ): Q4 FFO of $1.45 beats by $0.01 . Revenue of $3.18B (+41.3% Y/Y) beats by $190M . Shares -2.89% . Outlook for 2026 We are introducing our 2026 earnings guidance and expect to report net income attributable to common stockholders guidance in a range of $3.11 to $3.27 per diluted share and normalized FFO attributable to common stockholders in a range of $6.09 to $6.2...
Welltower press release ( WELL ): Q4 FFO of $1.45 beats by $0.01 . Revenue of $3.18B (+41.3% Y/Y) beats by $190M . Shares -2.89% . Outlook for 2026 We are introducing our 2026 earnings guidance and expect to report net income attributable to common stockholders guidance in a range of $3.11 to $3.27 per diluted share and normalized FFO attributable to common stockholders in a range of $6.09 to $6.25 per diluted share. In preparing our guidance, we have made the following assumptions: Same Store NOI: We expect average blended SSNOI growth of 11.25% to 15.75%, which is comprised of the following components: Seniors Housing Operating approximately 15.0% to 21.0% Seniors Housing Triple-net approximately 3.0% to 4.0% Outpatient Medical approximately 2.0% to 3.0% Long-Term/Post-Acute Care approximately 2.0% to 3.0% Investments: Our earnings guidance includes only those acquisitions announced or closed to date. Furthermore, no transitions, restructures or capital activity beyond those announced to date are included. General and Administrative Expenses: We anticipate general and administrative expenses to be approximately $260 million to $270 million. General and administrative guidance and 2026 normalized FFO guidance include anticipated stock-based compensation expense of approximately $60 million, or approximately $0.08 per diluted share. Development: We anticipate funding an additional $370 million of development in 2026 relating to projects underway as of December 31, 2025. Dispositions: We expect pro rata disposition proceeds of $3.5 billion at a blended yield of 6.8% in the next twelve months. This includes approximately $2.7 billion of consideration from expected property sales and $0.7 billion of expected proceeds from loan repayments. FY FFO consensus is $6.05 FY Revenue consensus is $12.49B More on Welltower Welltower Vs. American Healthcare REIT: Why The Latter Is The Better Buy Today Top performing healthcare REITs year to date Realty Income, FRT, other real est...
Tuesday, February 10, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Amazon.com, Inc. (AMZN) and Regeneron Pharmaceuticals, Inc. (REGN), as well as two micro-cap stocks National Presto Industries, Inc. (NPK) and AXIL Brands, Inc. (AXIL). The Zacks microcap r...
Tuesday, February 10, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Amazon.com, Inc. (AMZN) and Regeneron Pharmaceuticals, Inc. (REGN), as well as two micro-cap stocks National Presto Industries, Inc. (NPK) and AXIL Brands, Inc. (AXIL). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning. You can read today's AWS here >>> Retail Sales, Import/Export Prices & Q4 Earnings Hit the Tape Today's Featured Research Reports Shares of NVIDIA have gained +4.4% over the past six months against the Zacks Semiconductor - General industry’s gain of +6.2%. The company is benefiting from the strong growth of artificial intelligence (AI) and high-performance accelerated computing. The growing demand for generative AI and large language models using graphics processing units (GPUs) based on NVIDIA’s Hopper and Blackwell architectures is aiding data center revenues. The continued ramp-up of Ada RTX GPU workstations in the ProViz end market, following the normalization of channel inventory, is acting as a tailwind. Collaborations with more than 320 automakers and tier-one suppliers are likely to advance its presence in the autono...
Freshworks press release ( FRSH ): Q4 Non-GAAP EPS of $0.14 beats by $0.03 . Revenue of $222.7M (+14.4% Y/Y) beats by $3.94M . Cash, Cash Equivalents, Restricted Cash and Marketable Securities: Cash, cash equivalents, restricted cash and marketable securities were $843.7 million as of December 31, 2025. Full Year 2025 Financial Summary Results Revenue: Total revenue was $838.8 million, representin...
Freshworks press release ( FRSH ): Q4 Non-GAAP EPS of $0.14 beats by $0.03 . Revenue of $222.7M (+14.4% Y/Y) beats by $3.94M . Cash, Cash Equivalents, Restricted Cash and Marketable Securities: Cash, cash equivalents, restricted cash and marketable securities were $843.7 million as of December 31, 2025. Full Year 2025 Financial Summary Results Revenue: Total revenue was $838.8 million, representing growth of 16% compared to total revenue of $720.4 million in 2024, and 16% adjusting for constant currency. GAAP Income (Loss) from Operations: GAAP income (loss) from operations was $13.2 million, representing an operating margin of 1.6%, compared to $(138.6) million, representing an operating margin of (19.2)% in 2024. Non-GAAP Income from Operations: Non-GAAP income from operations was $178.0 million, representing a non-GAAP operating margin of 21.2%, compared to $99.1 million, representing a non-GAAP operating margin of 13.8%, in 2024. GAAP Net Income (Loss) Per Share: GAAP diluted net income (loss) per share was $0.63 based on 293.8 million weighted-average shares outstanding, compared to $(0.32) based on 300.8 million weighted-average shares outstanding in 2024. Non-GAAP Net Income Per Share: Non-GAAP diluted net income per share was $0.66 based on 293.8 million weighted-average shares outstanding, compared to $0.43 based on 305.1 million weighted-average shares outstanding in 2024. Net Cash Provided by Operating Activities: Net cash provided by operating activities was $242.4 million, representing an operating cash flow margin of 28.9%, compared to net cash provided by operating activities of $160.6 million, representing an operating cash flow margin of 22.3%, in 2024. Adjusted Free Cash Flow: Adjusted free cash flow was $223.1 million, representing an adjusted free cash flow margin of 26.6% compared to $153.3 million, representing an adjusted free cash flow margin of 21.3% in 2024. More on Freshworks Freshworks: Looks Cheap, But The Risk Is Higher Than It Seems Fr...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Abaxx Exchange’s new Excel integration and what it means for investors Abaxx Technologies (NEOE:ABXX) has announced a collaboration between Abaxx Exchange and ipushpull, allowing trading firms to stream Abaxx market data directly into Microsoft Excel, where many already track risk, positions...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Abaxx Exchange’s new Excel integration and what it means for investors Abaxx Technologies (NEOE:ABXX) has announced a collaboration between Abaxx Exchange and ipushpull, allowing trading firms to stream Abaxx market data directly into Microsoft Excel, where many already track risk, positions, and exposures. The integration lets users subscribe to Abaxx Exchange datasets, including historical and real-time feeds, with spreadsheet values updating automatically as new data is published across active contracts. See our latest analysis for Abaxx Technologies. Abaxx Technologies’ recent Excel integration news comes at a time when momentum in the share price has picked up again, with a 4.65% 1 day and 13.35% 7 day share price return. The 1 year total shareholder return is very large and points to a stock where expectations and perceived growth potential have already shifted significantly. If this kind of fintech infrastructure story has your attention, it can be helpful to see what else is out there in similar themes. Take a look at 18 cryptocurrency and blockchain stocks as a starting point for other market driven opportunities. With the share price already delivering a very large 1 year return and trading at what looks like a steep discount to the CA$68.33 analyst target and intrinsic estimates, is there still mispricing here, or is the market already banking on future growth? Preferred Price-to-Book of 34.3x: Is it justified? Abaxx Technologies last closed at CA$45.00, and based on a P/B ratio of 34.3x compared with both its software peers and the wider Canadian Software industry, the shares look richly priced on this metric. The price to book ratio compares a company’s market value to its net assets on the balance sheet. It is often used for early stage or asset light software names where profits are not yet established. A P/B of 34.3x suggests investors are payi...
Mattel press release ( MAT ): Q4 Non-GAAP EPS of $0.39 misses by $0.16 . Revenue of $1.77B (+7.9% Y/Y) misses by $60M . FY26 revenue consensus of $5.62B, Non-GAAP EPS consensus of $1.76. Mattel’s full year 2026 guidance is: (in millions,except EPS and percentages) FY2026 Guidance FY2025 Actual Net Sales +3% to 6%* $5,348 Adjusted Gross Margin Approx. 50% 48.9% Adjusted Operating Income $550 - $600...
Mattel press release ( MAT ): Q4 Non-GAAP EPS of $0.39 misses by $0.16 . Revenue of $1.77B (+7.9% Y/Y) misses by $60M . FY26 revenue consensus of $5.62B, Non-GAAP EPS consensus of $1.76. Mattel’s full year 2026 guidance is: (in millions,except EPS and percentages) FY2026 Guidance FY2025 Actual Net Sales +3% to 6%* $5,348 Adjusted Gross Margin Approx. 50% 48.9% Adjusted Operating Income $550 - $600 $620 Adjusted Tax Rate Approx. 24% 20% Adjusted EPS $1.18 - $1.30 $1.41 Click to enlarge Shares -8.3% . More on Mattel Mattel Is Set For Acceleration In 2026 Mattel, Inc. (MAT) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript Mattel Q4 2025 Earnings Preview Mattel has a KPop Demon Hunters doll plan Seeking Alpha’s Quant Rating on Mattel
Diodes press release ( DIOD ): Q4 Non-GAAP EPS of $0.34 beats by $0.07 . Revenue of $391.58M (+15.4% Y/Y) beats by $11.55M . Gary Yu said, “For the first quarter of 2026, we expect revenue to be approximately $395 million, plus or minus 3 percent, representing a 19 percent increase year-over-year and a slight increase sequentially at the mid-point, which is significantly better than typical season...
Diodes press release ( DIOD ): Q4 Non-GAAP EPS of $0.34 beats by $0.07 . Revenue of $391.58M (+15.4% Y/Y) beats by $11.55M . Gary Yu said, “For the first quarter of 2026, we expect revenue to be approximately $395 million, plus or minus 3 percent, representing a 19 percent increase year-over-year and a slight increase sequentially at the mid-point, which is significantly better than typical seasonality. GAAP gross margin is expected to be 31.5 percent, plus or minus 1 percent. Non-GAAP operating expenses, which are GAAP operating expenses adjusted for amortization of acquisition-related intangible assets, are expected to be approximately 26.5 percent of revenue, plus or minus 1 percent. We expect net interest income to be approximately $1.0 million. Our income tax rate is expected to be 18.5 percent, plus or minus 3 percent, and shares used to calculate diluted EPS for the first quarter are anticipated to be approximately 46.4 million.” Shares +5.5% AH. More on Diodes Diodes Incorporated: How Nexperia Could Shape The Path Ahead Diodes Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Diodes Historical earnings data for Diodes Financial information for Diodes